Effect of a Mobile App on Improving Asthma Control in Patients With Persistent Asthma (NCT05129527) | Clinical Trial Compass
UnknownNot Applicable
Effect of a Mobile App on Improving Asthma Control in Patients With Persistent Asthma
Portugal124 participantsStarted 2024-01
Plain-language summary
mINSPIRERS\_RCT aims to assess the magnitude of the effect of a mobile app for improving asthma control in adolescents and adults with persistent asthma, followed at primary and secondary care in Portugal.
Who can participate
Age range13 Years – 64 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 13 and 17 years (adolescents) or and between 18 and 64 years (adults);
* Previous medical diagnosis of persistent asthma;
* Uncontrolled or partially controlled asthma according to Global Initiative for Asthma (GINA) criteria;
* Active prescription of inhaled control medication for asthma (all treatments will be accepted. There will be no change in the prescribed therapeutic regimen directly or indirectly related to participation in this study);
* Ability to use mobile app and a access (availability and use) to Android mobile devices with internet access;
* Do not currently use any mobile application for asthma management.
Exclusion Criteria:
* Patients diagnosed with chronic respiratory disease other than asthma or, diagnosed with another significant chronic disease, with possible interference with the objectives and/or evaluations of the study.
* Patients that participated in previous feasibility studies with InspirerMundi app will be excluded.